New attenuation marker for junin virus based on immunologic responses of guinea pigs.
A new attenuation marker to distinguish a virulent strain (XJJV) from an attenuated strain (XJC13JV or XJOJV) of Junin virus by means of the humoral and cellular responses to unrelated antigens was studied in guinea pigs. Strain XJJV suppressed the humoral immune response, as shown by the lower titers of precipitating antibody to ovalbumin. The concomitant decrease in serum complement level contributed to a milder Arthus cutaneous reactivity. In contrast, the attenuated strains did not decrease the humoral response. The pathogenic strain suppressed cell-mediated immunity, as demonstrated by decreased contact sensitivity to 2,4-dinitro-1-fluorobenzene and by depression of delayed skin reactions to tuberculin purified protein derivative. When attenuated strains were used, such suppressive effects were not observed. For virulent strain XJJV, virus replication in lymphoid organs and immunosuppressive effects were correlated. These findings provide a further means to differentiate between virulent and attenuated strains of Junin virus for the purpose of vaccine control of Argentine hemorrhagic fever.
D000818:Animals; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation; D001116:Arenaviridae / Q000502:physiology*; D006477:Arenaviruses, New World / Q000502:physiology*; D001183:Arthus Reaction / Q000276:immunology; D003877:Dermatitis, Contact / Q000276:immunology; D004139:Dinitrofluorobenzene; D005260:Female; D006168:Guinea Pigs; D007111:Immunity, Cellular; D008297:Male; D010047:Ovalbumin / Q000276:immunology; D014374:Tuberculin Test; D014613:Vaccines, Attenuated / Q000032:analysis; D014774:Virulence
D000906:Antibodies; D014613:Vaccines, Attenuated; D010047:Ovalbumin; D004139:Dinitrofluorobenzene